#CellTherapy $TAK $FATE $NK @CellMedica & Century Therapeutics
![](https://pbs.twimg.com/media/EQIS3JHUwAAUs_U.png)
![](https://pbs.twimg.com/media/EQIS3JFU8AAyga0.jpg)
![](https://pbs.twimg.com/media/EQIS3JVUcAA9bns.jpg)
![](https://pbs.twimg.com/media/EQIS3JWUcAALMWc.jpg)
@NEJM paper: nejm.org/doi/full/10.10…
$TAK has licensed this product. Competitively relevant to $FATE.
![](https://pbs.twimg.com/media/EQIZnbGUwAAJYMO.jpg)
![](https://pbs.twimg.com/media/EQIZnbIU4AA-fpq.png)
![](https://pbs.twimg.com/media/EQIZnbMVUAA-Xb0.jpg)
![](https://pbs.twimg.com/media/EQIZnbsU8AA6sLs.jpg)
Gilead will pay an undisclosed upfront and milestones. $KITE @oNKo_innate
Relevant to $FATE $JNJ $TAK $NK
gilead.com/news-and-press…
Paper: nature.com/articles/s4156…
![](https://pbs.twimg.com/media/EbYT7gdUYAIEBbA.jpg)
![](https://pbs.twimg.com/media/EbYT7geUwAAewZw.png)
![](https://pbs.twimg.com/media/EbYT7ggU4AEFDhg.png)
![](https://pbs.twimg.com/media/EbYT7ghU8AAUiSc.png)